(Q42801165)

English

Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities

scientific article published on January 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 November 2017

Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities (English)

1 reference

Europe PubMed Central

7 November 2017

0 references

author name string

B T Hill

1

1 reference

Europe PubMed Central

7 November 2017

R D Whelan

2

1 reference

Europe PubMed Central

7 November 2017

publication date

1 January 1982

1 reference

Europe PubMed Central

7 November 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

7 November 2017

8

1 reference

Europe PubMed Central

7 November 2017

163-169

1 reference

Europe PubMed Central

7 November 2017

2

1 reference

Europe PubMed Central

7 November 2017

describes a project that uses

0 references

0 references

https://scigraph.springernature.com/pub.10.1007/bf00255477

0 references

Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uptake and binding of vincristine by murine leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lethal and kinetic effects of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and II studies of vindesine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies in histochemistry. I. Determination of nucleic acids in microgram amounts of tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental in vivo cross-resistance of vinca alkaloid drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of adriamycin in overcoming resistance to methotrexate in tissue culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow microfluorometric estimation of G1 and G2 chalone inhibition of the JB-1 tumour cell cycle in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to 4'-demethylepipodophyllotoxin ethylidene-beta-D-glucoside

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vindesine as a single agent in the treatment of advanced malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate resistance and uptake of DDMP by L5178Y cells. Selective protection with folinic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered glycosidase levels in drug-resistant mouse leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetyl vinblastine amide (vindesine) sulfate

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vindesine trials at Memorial Sloan-Kettering Cancer Center

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7105380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00255477

1 reference

Europe PubMed Central

7 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42801165&oldid=1970821740"